1,008 results on '"Kubica, Jacek"'
Search Results
52. Pretreatment with P2Y12 Receptor Inhibitors in Acute Coronary Syndromes—Is the Current Standpoint of ESC Experts Sufficiently Supported?
53. Comparison of reorganized versus unaltered cardiology departments during the COVID-19 era: a subanalysis of the COV-HF-SIRIO 6 study
54. PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection
55. Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors
56. Acetylsalicylic acid resistance risk factors in patients with myocardial infarction
57. Transcathether aortic valve implantation with the new repositionable self-expandable Medtronic Evolut R vs. CoreValve system: evidence on the benefit of a meta-analytical approach
58. Andexanet alfa -- Recommendations for clinical use. Multidisciplinary experts' standpoint.
59. The number of circulating endothelial progenitor cells in healthy individuals – Effect of some anthropometric and environmental factors (a pilot study)
60. A novel multiplex assay amplifying 13 Y-STRs characterized by rapid and moderate mutation rate
61. Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome
62. Percutaneous closure of the iatrogenic atrial septal defect following the transcatheter edge-to-edge mitral valve repair with MitraClip system led to instant improvement of hypoxemia — case report
63. The impact of the COVID-19 pandemic on hospital functioning and mortality among non-COVID-19 patients
64. Functioning in chronic disease — a key factor determining adherence to heart failure treatment
65. Clinical Characteristics and Predictors of In-Hospital Mortality of Patients Hospitalized with COVID-19 Infection
66. Analysis of planar waveguides with a thin overlayer and nonlinear cladding
67. Mild therapeutic hypothermia or targeted temperature management for cardiac arrest survivors?
68. Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs after Vaccination (DANTE-SIRIO 7) Study in a Large Cohort of Healthcare Workers
69. Diurnal Oscillations of Fibrinolytic Parameters in Patients with Acute Myocardial Infarction and Their Relation to Platelet Reactivity: Preliminary Insights
70. Summary of the European Society of Cardiology guidelines on dual antiplatelet therapy in patients after percutaneous coronary interventions
71. Conley-Morse-Forman theory for generalized combinatorial multivector fields on finite topological spaces
72. Opioids and oral P2Y12 receptor inhibitors: A drug–drug interaction
73. Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The ReCOVery-SIRIO randomized trial
74. Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction—The REC-DUT-002 Trial
75. Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment–Elevation Myocardial Infarction: Results of REAL-TIMI 63B
76. Reversal of Platelet Inhibition in Patients Receiving Ticagrelor
77. Long-term outcomes following drug-eluting balloons vs. thin-strut drug-eluting stents for treatment of recurrent restenosis in drug-eluting stents
78. Longer Hospitalizations and Higher In-Hospital Mortality for Acute Heart Failure during the COVID-19 Pandemic in Larger vs. Smaller Cardiology Departments: Subanalysis of the COV-HF-SIRIO 6 Multicenter Study
79. Does ticagrelor effectively inhibit platelets in patients undergoing mild therapeutic hypothermia or it does not?
80. Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022
81. The spoils of war and the long-term spoiling of health conditions of entire nations
82. Meta-Analysis of Time-Related Benefits of Statin Therapy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
83. Comparative performance of transcatheter aortic valve-in-valve implantation versus conventional surgical redo aortic valve replacement in patients with degenerated aortic valve bioprostheses: systematic review and meta-analysis
84. Abstract 20229: Comparative Methods to Estimate the Relationship Between LDL Cholesterol Reduction and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
85. Long-term outcome of rotational atherectomy according to burr-to-artery ratio and changes in coronary artery blood flow: Observational analysis.
86. Efficacy of double vs. standard empagliflozin dose for METabolic syndromE tReatment (DEMETER — SIRIO 11) study. Rationale and protocol of the study.
87. Metabolism of ticagrelor in patients with acute coronary syndromes
88. Admission glucose and left ventricular systolic function in non-diabetic patients with acute myocardial infarction
89. Guidelines, recommendations, position papers and experts’ opinions — should we establish rules for creating rules?
90. The impact of mild therapeutic hypothermia on platelet reactivity in comatose survivors of cardiac arrest with acute myocardial infarction treated with ticagrelor
91. Management and predictors of clinical events in 75 686 patients with acute myocardial infarction
92. Clinical use of intracoronary imaging modalities in Poland. Expert opinion of the Association of Cardiovascular Interventions of the Polish Cardiac Society
93. Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
94. Pretreatment with P2Y 12 Receptor Inhibitors in Acute Coronary Syndromes—Is the Current Standpoint of ESC Experts Sufficiently Supported?
95. Early administration of LEvosimendan in Patients witH decompensAted chroNic hearT failure (ELEPHANT) study. Rationale and protocol of the study.
96. Inhibitors of sodium-glucose transport protein 2: A new multidirectional therapeutic option for heart failure patients.
97. Twelve-month results of a Paclitaxel Releasing Balloon in Patients Presenting with In-stent Restenosis First-in-Man (PEPPER) trial
98. Ticagrelor, but not clopidogrel and prasugrel, prevents ADP-induced vascular smooth muscle cell contraction: A placebo-controlled study in rats
99. Prehospital treatment of patients with acute coronary syndrome
100. IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the SARS-COV-2 infection: Rationale and protocol of the IMPACT-SIRIO 5 study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.